The primary objective of this project is to discover multi-target compounds—both natural and synthetic—capable of simultaneously inhibiting TYR, TRP-1/2, and MITF, with applications in the medical-pharmaceutical, cosmetic, and agrochemical industries. The project will prioritize and focus experimental testing on the most promising compounds in order to improve therapeutic efficacy in the treatment of melanoma and hyperpigmentation disorders.
Researchers: Dr . Yovani Marrero and Dr. Félix Martínez.







